Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tbr1
|
ENSMUSG00000035033.9 | T-box brain transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_61804372_61804840 | Tbr1 | 153 | 0.951945 | 0.67 | 1.9e-08 | Click! |
chr2_61803806_61804342 | Tbr1 | 379 | 0.847947 | 0.60 | 1.1e-06 | Click! |
chr2_61804958_61805340 | Tbr1 | 696 | 0.665620 | 0.54 | 2.2e-05 | Click! |
chr2_61803440_61803684 | Tbr1 | 632 | 0.696727 | 0.54 | 2.2e-05 | Click! |
chr2_61807134_61807469 | Tbr1 | 1028 | 0.516030 | 0.52 | 5.1e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_65961618_65962124 | 21.64 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr5_77207847_77208140 | 19.03 |
Spink2 |
serine peptidase inhibitor, Kazal type 2 |
3212 |
0.19 |
chr3_107479647_107479853 | 17.26 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
11045 |
0.17 |
chr3_107479176_107479476 | 16.76 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
10621 |
0.18 |
chr8_105320451_105321442 | 15.01 |
Lrrc29 |
leucine rich repeat containing 29 |
5313 |
0.07 |
chr5_22262595_22262780 | 12.00 |
Gm16113 |
predicted gene 16113 |
18895 |
0.17 |
chr3_151551098_151551520 | 11.84 |
Adgrl4 |
adhesion G protein-coupled receptor L4 |
33880 |
0.19 |
chr16_14265466_14265813 | 10.43 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr7_18926314_18927174 | 10.39 |
Nova2 |
NOVA alternative splicing regulator 2 |
856 |
0.42 |
chr17_13590938_13591623 | 9.95 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr2_127521161_127522051 | 9.88 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr16_27925573_27925782 | 9.77 |
Gm49765 |
predicted gene, 49765 |
44668 |
0.17 |
chr8_12214132_12214283 | 9.73 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
64612 |
0.1 |
chr3_68072068_68072422 | 9.64 |
Schip1 |
schwannomin interacting protein 1 |
7443 |
0.3 |
chr6_5739397_5739548 | 9.57 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
13654 |
0.3 |
chr5_90987721_90988058 | 9.43 |
Epgn |
epithelial mitogen |
39575 |
0.11 |
chr2_178840979_178841397 | 8.94 |
Gm14314 |
predicted gene 14314 |
179945 |
0.03 |
chr3_107478972_107479135 | 8.93 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
10348 |
0.18 |
chr16_33605736_33606716 | 8.84 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr12_50084531_50084873 | 8.76 |
Gm40418 |
predicted gene, 40418 |
35607 |
0.24 |
chr10_81364518_81366962 | 8.74 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr3_83997060_83997321 | 8.71 |
Tmem131l |
transmembrane 131 like |
28962 |
0.2 |
chr5_23181308_23181459 | 8.55 |
Gm42948 |
predicted gene 42948 |
42413 |
0.15 |
chr1_41605849_41606032 | 8.45 |
Gm28634 |
predicted gene 28634 |
76397 |
0.12 |
chr4_138504549_138504859 | 8.43 |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
50390 |
0.1 |
chr9_9899193_9899359 | 8.35 |
Mir6237 |
microRNA 6237 |
4845 |
0.35 |
chr12_6638821_6639107 | 8.34 |
Gm48619 |
predicted gene, 48619 |
60789 |
0.16 |
chr19_14436131_14436458 | 8.31 |
Tle4 |
transducin-like enhancer of split 4 |
159245 |
0.04 |
chr16_41900909_41901060 | 8.24 |
Lsamp |
limbic system-associated membrane protein |
243000 |
0.02 |
chr3_68096841_68096992 | 8.16 |
Schip1 |
schwannomin interacting protein 1 |
32114 |
0.23 |
chr4_117406049_117406200 | 8.08 |
Rnf220 |
ring finger protein 220 |
30667 |
0.13 |
chr10_14179666_14179832 | 8.03 |
Gm48843 |
predicted gene, 48843 |
17266 |
0.15 |
chr13_29273638_29274140 | 8.00 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr13_29550246_29550563 | 7.96 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
32950 |
0.24 |
chr3_85159760_85160220 | 7.95 |
Gm38041 |
predicted gene, 38041 |
7294 |
0.26 |
chr19_55424034_55424281 | 7.64 |
Vti1a |
vesicle transport through interaction with t-SNAREs 1A |
43143 |
0.18 |
chr10_30343195_30343371 | 7.61 |
Gm4780 |
predicted gene 4780 |
29635 |
0.21 |
chr5_149492062_149492213 | 7.36 |
Gm2566 |
predicted gene 2566 |
10915 |
0.13 |
chr8_45715387_45715853 | 7.27 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
27283 |
0.17 |
chrY_90739614_90740540 | 7.20 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr14_14885989_14886140 | 7.16 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
20842 |
0.23 |
chr5_49639734_49639933 | 7.06 |
Gm5555 |
predicted pseudogene 5555 |
87675 |
0.08 |
chr16_50585962_50586298 | 7.00 |
4930542D17Rik |
RIKEN cDNA 4930542D17 gene |
4373 |
0.22 |
chr9_120869974_120870286 | 6.98 |
Gm34425 |
predicted gene, 34425 |
184 |
0.83 |
chr6_29036732_29037045 | 6.98 |
Mir129-1 |
microRNA 129-1 |
14269 |
0.16 |
chr9_73258155_73258537 | 6.91 |
Gm27211 |
predicted gene 27211 |
65863 |
0.09 |
chr12_117988999_117989757 | 6.77 |
Dnah11 |
dynein, axonemal, heavy chain 11 |
70925 |
0.12 |
chr3_145890165_145890867 | 6.65 |
Rpl36a-ps2 |
ribosomal protein L36A, pseudogene 2 |
11496 |
0.18 |
chr17_9543267_9543689 | 6.65 |
Gm49807 |
predicted gene, 49807 |
6213 |
0.28 |
chr10_3417310_3417750 | 6.56 |
Gm24482 |
predicted gene, 24482 |
7493 |
0.25 |
chr8_65617940_65618821 | 6.55 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr12_7028540_7028691 | 6.54 |
Gm46311 |
predicted gene, 46311 |
61655 |
0.16 |
chr11_22858998_22860305 | 6.43 |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
106 |
0.89 |
chr4_124593762_124594036 | 6.34 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
24709 |
0.14 |
chr2_106083913_106084082 | 6.33 |
Gm29053 |
predicted gene 29053 |
43501 |
0.12 |
chr16_35592451_35593042 | 6.21 |
Gm5963 |
predicted pseudogene 5963 |
19190 |
0.18 |
chr7_126897934_126898711 | 6.21 |
Tmem219 |
transmembrane protein 219 |
41 |
0.92 |
chr13_84569455_84569857 | 6.19 |
Gm26913 |
predicted gene, 26913 |
121285 |
0.06 |
chr8_16614504_16614815 | 6.17 |
Gm45393 |
predicted gene 45393 |
67417 |
0.13 |
chr9_84032652_84032865 | 6.16 |
Bckdhb |
branched chain ketoacid dehydrogenase E1, beta polypeptide |
3082 |
0.26 |
chr12_27248179_27248503 | 6.15 |
Gm47860 |
predicted gene, 47860 |
15165 |
0.27 |
chr6_93395341_93395563 | 6.14 |
Gm25094 |
predicted gene, 25094 |
59864 |
0.12 |
chr13_112278397_112278548 | 6.12 |
Ankrd55 |
ankyrin repeat domain 55 |
9979 |
0.18 |
chr6_6871537_6871723 | 6.11 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
38 |
0.96 |
chr10_81559146_81561402 | 6.06 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chrX_130189358_130189529 | 6.05 |
Gm14984 |
predicted gene 14984 |
212776 |
0.02 |
chr5_97537996_97538189 | 6.03 |
Gk2 |
glycerol kinase 2 |
81071 |
0.1 |
chr11_107390179_107390330 | 6.03 |
Gm11712 |
predicted gene 11712 |
3271 |
0.18 |
chr4_22973852_22974022 | 6.01 |
1700025O08Rik |
RIKEN cDNA 1700025O08 gene |
35502 |
0.23 |
chr5_35879306_35879482 | 6.00 |
Afap1 |
actin filament associated protein 1 |
13925 |
0.19 |
chr18_46113230_46113403 | 5.99 |
Gm38337 |
predicted gene, 38337 |
57 |
0.98 |
chr12_28700549_28700979 | 5.99 |
Trappc12 |
trafficking protein particle complex 12 |
845 |
0.53 |
chr6_55921320_55921515 | 5.97 |
Itprid1 |
ITPR interacting domain containing 1 |
34592 |
0.21 |
chr2_50835577_50835754 | 5.97 |
Gm13498 |
predicted gene 13498 |
74019 |
0.12 |
chr1_190660079_190660272 | 5.94 |
Gm30932 |
predicted gene, 30932 |
65849 |
0.12 |
chr7_51662439_51662822 | 5.93 |
Gm45072 |
predicted gene 45072 |
30905 |
0.14 |
chr5_122648020_122648335 | 5.90 |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
2247 |
0.21 |
chr12_44401957_44402486 | 5.89 |
Gm48182 |
predicted gene, 48182 |
7569 |
0.2 |
chr9_83098721_83098917 | 5.88 |
Gm38398 |
predicted gene, 38398 |
595 |
0.67 |
chr2_17730264_17731671 | 5.88 |
Nebl |
nebulette |
76 |
0.98 |
chr10_81176405_81177305 | 5.87 |
Eef2 |
eukaryotic translation elongation factor 2 |
224 |
0.79 |
chr3_105538840_105539458 | 5.85 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr18_19112283_19112434 | 5.84 |
Gm31086 |
predicted gene, 31086 |
20859 |
0.29 |
chr9_121606831_121606982 | 5.83 |
Lyzl4os |
lysozyme-like 4, opposite strand |
4062 |
0.16 |
chr10_56485021_56485217 | 5.82 |
Gm9118 |
predicted gene 9118 |
12222 |
0.22 |
chr6_124915577_124916697 | 5.81 |
Ptms |
parathymosin |
608 |
0.37 |
chr5_77806307_77806485 | 5.79 |
Gm42673 |
predicted gene 42673 |
103064 |
0.07 |
chr2_50044863_50045062 | 5.74 |
Lypd6 |
LY6/PLAUR domain containing 6 |
21467 |
0.27 |
chr7_68400621_68400772 | 5.73 |
Gm44889 |
predicted gene 44889 |
15650 |
0.13 |
chr16_85896033_85896184 | 5.73 |
Adamts5 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) |
5720 |
0.28 |
chr10_80145825_80146996 | 5.70 |
Midn |
midnolin |
1862 |
0.15 |
chr13_29195836_29196009 | 5.69 |
Gm11364 |
predicted gene 11364 |
40698 |
0.19 |
chr1_57330254_57330423 | 5.69 |
Gm5254 |
predicted gene 5254 |
37937 |
0.12 |
chr10_108710601_108710798 | 5.68 |
Gm5136 |
predicted gene 5136 |
10539 |
0.26 |
chr16_72222039_72222224 | 5.64 |
8030451O07Rik |
RIKEN cDNA 8030451O07 gene |
12171 |
0.29 |
chr13_14517540_14517698 | 5.62 |
Gm30893 |
predicted gene, 30893 |
3867 |
0.2 |
chr12_44403738_44404185 | 5.59 |
Gm48182 |
predicted gene, 48182 |
5829 |
0.21 |
chr7_95726264_95726419 | 5.58 |
Gm5037 |
predicted gene 5037 |
187045 |
0.03 |
chr16_25960424_25960638 | 5.55 |
Gm4524 |
predicted gene 4524 |
4056 |
0.28 |
chr16_57863683_57863834 | 5.55 |
Gm24039 |
predicted gene, 24039 |
20381 |
0.16 |
chr3_61846680_61846847 | 5.55 |
Gm9700 |
predicted gene 9700 |
223031 |
0.02 |
chr16_62686085_62686411 | 5.54 |
Gm9816 |
predicted pseudogene 9816 |
30789 |
0.18 |
chr7_101633949_101634127 | 5.51 |
Clpb |
ClpB caseinolytic peptidase B |
29595 |
0.13 |
chr10_111130011_111130185 | 5.51 |
Gm22101 |
predicted gene, 22101 |
889 |
0.49 |
chr13_6306939_6307331 | 5.50 |
Gm35615 |
predicted gene, 35615 |
12421 |
0.23 |
chr6_32373792_32373943 | 5.50 |
Plxna4os3 |
plexin A4, opposite strand 3 |
69954 |
0.11 |
chr1_23098558_23098709 | 5.48 |
Ppp1r14bl |
protein phosphatase 1, regulatory inhibitor subunit 14B like |
3620 |
0.31 |
chr13_83985066_83985623 | 5.48 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr8_37291540_37291737 | 5.47 |
Gm25126 |
predicted gene, 25126 |
25940 |
0.16 |
chr11_35856666_35857239 | 5.42 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
3398 |
0.24 |
chr8_99631118_99631288 | 5.42 |
Gm8688 |
predicted gene 8688 |
32816 |
0.23 |
chr15_57733279_57733651 | 5.39 |
9330154K18Rik |
RIKEN cDNA 9330154K18 gene |
5201 |
0.22 |
chr15_44764462_44764687 | 5.39 |
Sybu |
syntabulin (syntaxin-interacting) |
12116 |
0.21 |
chr17_62337960_62338171 | 5.33 |
Gm49860 |
predicted gene, 49860 |
97992 |
0.09 |
chr16_45999549_45999806 | 5.30 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
10541 |
0.16 |
chr2_80129445_80129882 | 5.29 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
205 |
0.94 |
chr18_8871292_8871740 | 5.28 |
Gm37148 |
predicted gene, 37148 |
56719 |
0.14 |
chr4_36183692_36183983 | 5.27 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
47374 |
0.2 |
chr1_144151888_144152189 | 5.27 |
Rgs13 |
regulator of G-protein signaling 13 |
25237 |
0.22 |
chr14_108709180_108709331 | 5.26 |
Rpl27a-ps2 |
ribosomal protein L27A, pseudogene 2 |
16612 |
0.28 |
chr13_34096148_34096452 | 5.25 |
Gm47065 |
predicted gene, 47065 |
7273 |
0.1 |
chr13_11281870_11282060 | 5.23 |
Gm25496 |
predicted gene, 25496 |
144933 |
0.05 |
chr14_103613671_103614004 | 5.22 |
Slain1 |
SLAIN motif family, member 1 |
36391 |
0.16 |
chr12_26886622_26886951 | 5.21 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
51913 |
0.18 |
chr8_4206127_4207837 | 5.21 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr7_31127074_31128340 | 5.19 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr2_168253889_168254106 | 5.16 |
Gm14237 |
predicted gene 14237 |
11567 |
0.11 |
chr8_8621177_8621592 | 5.16 |
Gm45075 |
predicted gene 45075 |
9120 |
0.1 |
chr6_141568677_141568868 | 5.14 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
22608 |
0.23 |
chr2_105284895_105285179 | 5.14 |
Them7 |
thioesterase superfamily member 7 |
60695 |
0.12 |
chr13_8567482_8568009 | 5.14 |
Gm48262 |
predicted gene, 48262 |
14725 |
0.26 |
chr2_79459975_79460605 | 5.14 |
Cerkl |
ceramide kinase-like |
3505 |
0.25 |
chr2_159235233_159235387 | 5.13 |
Gm25090 |
predicted gene, 25090 |
95949 |
0.09 |
chr2_126932364_126933545 | 5.11 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr13_6307436_6307642 | 5.11 |
Gm35615 |
predicted gene, 35615 |
12825 |
0.23 |
chr14_35095601_35095765 | 5.07 |
Gm49034 |
predicted gene, 49034 |
123755 |
0.06 |
chr4_30268060_30268211 | 5.07 |
Gm11925 |
predicted gene 11925 |
74488 |
0.13 |
chr3_52784594_52784745 | 5.06 |
Gm30292 |
predicted gene, 30292 |
13116 |
0.19 |
chr3_158175205_158175397 | 5.06 |
Gm42968 |
predicted gene 42968 |
4935 |
0.23 |
chr1_186988549_186988700 | 5.05 |
Gm19058 |
predicted gene, 19058 |
17980 |
0.13 |
chr13_24048705_24048856 | 5.05 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
10539 |
0.17 |
chr1_34298690_34298863 | 5.04 |
Dst |
dystonin |
4330 |
0.17 |
chrX_102082357_102082546 | 5.04 |
Nhsl2 |
NHS-like 2 |
9509 |
0.13 |
chr8_99630935_99631100 | 5.03 |
Gm8688 |
predicted gene 8688 |
33002 |
0.23 |
chr11_110457599_110457941 | 5.03 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
19607 |
0.25 |
chr15_27145944_27146195 | 4.99 |
Gm23903 |
predicted gene, 23903 |
84203 |
0.1 |
chr9_10667519_10667670 | 4.99 |
Gm7529 |
predicted gene 7529 |
67046 |
0.14 |
chr5_20056465_20056826 | 4.99 |
Gm23570 |
predicted gene, 23570 |
35970 |
0.2 |
chr13_32531016_32531402 | 4.98 |
Gm48073 |
predicted gene, 48073 |
5206 |
0.28 |
chr14_60415071_60415222 | 4.96 |
Gm6066 |
predicted gene 6066 |
26833 |
0.17 |
chr9_13246797_13247848 | 4.96 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr2_12709166_12709591 | 4.96 |
Gm37565 |
predicted gene, 37565 |
11961 |
0.29 |
chr3_120570837_120570994 | 4.95 |
Gm25013 |
predicted gene, 25013 |
39178 |
0.22 |
chr13_77892438_77892993 | 4.93 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
132187 |
0.05 |
chr6_55920965_55921278 | 4.93 |
Itprid1 |
ITPR interacting domain containing 1 |
34296 |
0.21 |
chr1_85089758_85090158 | 4.92 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr18_26228071_26228248 | 4.91 |
Gm33228 |
predicted gene, 33228 |
215856 |
0.02 |
chr4_28895623_28895804 | 4.90 |
Epha7 |
Eph receptor A7 |
23789 |
0.24 |
chr8_69149162_69149554 | 4.87 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
8405 |
0.17 |
chr1_51650752_51650944 | 4.86 |
Gm28055 |
predicted gene 28055 |
47052 |
0.14 |
chr13_116575625_116575931 | 4.86 |
Gm47913 |
predicted gene, 47913 |
87758 |
0.08 |
chr2_57793598_57793749 | 4.85 |
Gm25388 |
predicted gene, 25388 |
139851 |
0.04 |
chr4_98686838_98687013 | 4.82 |
Gm12846 |
predicted gene 12846 |
22559 |
0.14 |
chr3_139885937_139886924 | 4.82 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr17_73713338_73713695 | 4.80 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
3063 |
0.29 |
chr3_68513686_68514094 | 4.78 |
Schip1 |
schwannomin interacting protein 1 |
19682 |
0.2 |
chr1_69535646_69535797 | 4.77 |
Gm29114 |
predicted gene 29114 |
21789 |
0.19 |
chr13_58964694_58965094 | 4.77 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
93159 |
0.06 |
chr10_81472309_81472908 | 4.75 |
Celf5 |
CUGBP, Elav-like family member 5 |
394 |
0.64 |
chr8_45712735_45712886 | 4.75 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
24473 |
0.18 |
chr15_71810647_71810819 | 4.74 |
Gm16308 |
predicted gene 16308 |
625 |
0.69 |
chr13_34095941_34096108 | 4.73 |
Gm47065 |
predicted gene, 47065 |
6997 |
0.11 |
chr15_85494388_85494565 | 4.73 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
8751 |
0.19 |
chr19_38054215_38055320 | 4.73 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr7_79592943_79593212 | 4.72 |
Gm45169 |
predicted gene 45169 |
464 |
0.65 |
chr15_92743865_92744028 | 4.72 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
303 |
0.93 |
chr6_147948090_147948241 | 4.72 |
Far2 |
fatty acyl CoA reductase 2 |
99094 |
0.07 |
chr1_90174493_90174644 | 4.71 |
4930434B07Rik |
RIKEN cDNA 4930434B07 gene |
20940 |
0.15 |
chr12_44409864_44410015 | 4.71 |
Gm48182 |
predicted gene, 48182 |
149 |
0.96 |
chr1_190728840_190729282 | 4.71 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
81402 |
0.09 |
chrX_118596164_118596357 | 4.70 |
Gm7485 |
predicted gene 7485 |
102643 |
0.08 |
chr8_127958753_127958904 | 4.69 |
Mir21c |
microRNA 21c |
319397 |
0.01 |
chr6_47228750_47229021 | 4.69 |
Cntnap2 |
contactin associated protein-like 2 |
15502 |
0.28 |
chr14_93451377_93451568 | 4.68 |
Gm48964 |
predicted gene, 48964 |
140335 |
0.05 |
chr16_77593811_77594374 | 4.66 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
264 |
0.83 |
chr16_76950938_76951119 | 4.65 |
Gm7501 |
predicted gene 7501 |
9412 |
0.23 |
chr13_77388216_77388555 | 4.64 |
Gm9634 |
predicted gene 9634 |
165988 |
0.03 |
chr17_89090010_89090391 | 4.64 |
Fshr |
follicle stimulating hormone receptor |
110475 |
0.07 |
chr2_10410212_10410363 | 4.63 |
Gm13261 |
predicted gene 13261 |
36246 |
0.02 |
chr3_28564763_28565153 | 4.63 |
Tnik |
TRAF2 and NCK interacting kinase |
26680 |
0.22 |
chr1_172203581_172203997 | 4.62 |
Pea15a |
phosphoprotein enriched in astrocytes 15A |
2908 |
0.13 |
chr7_109328874_109329033 | 4.60 |
Gm9105 |
predicted gene 9105 |
59922 |
0.1 |
chr1_98162340_98162491 | 4.60 |
Gm29461 |
predicted gene 29461 |
11233 |
0.2 |
chr18_9464256_9464407 | 4.60 |
Ccny |
cyclin Y |
14177 |
0.15 |
chr1_75725382_75725667 | 4.60 |
Gm5257 |
predicted gene 5257 |
89134 |
0.07 |
chr7_79535477_79536145 | 4.59 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr7_53109424_53109575 | 4.58 |
Gm22444 |
predicted gene, 22444 |
182429 |
0.03 |
chr13_83988136_83988456 | 4.57 |
Gm4241 |
predicted gene 4241 |
305 |
0.91 |
chr3_141197596_141197758 | 4.57 |
Pdha2 |
pyruvate dehydrogenase E1 alpha 2 |
14678 |
0.29 |
chr4_91230669_91230848 | 4.56 |
Elavl2 |
ELAV like RNA binding protein 1 |
23824 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.1 | 9.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
2.8 | 8.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.3 | 9.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.1 | 6.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.9 | 5.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.8 | 12.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.8 | 12.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.7 | 3.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.7 | 5.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.6 | 7.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.5 | 11.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.5 | 2.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.4 | 4.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.4 | 4.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.4 | 5.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
1.4 | 5.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.4 | 5.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.3 | 4.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.3 | 4.0 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.3 | 4.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.3 | 3.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.3 | 7.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.3 | 3.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.3 | 3.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.3 | 3.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.2 | 6.2 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.2 | 2.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.1 | 1.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.1 | 4.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 | 3.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.1 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 3.4 | GO:0021564 | vagus nerve development(GO:0021564) |
1.1 | 3.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 3.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.1 | 4.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.1 | 13.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.1 | 9.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.0 | 3.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.0 | 3.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.0 | 4.1 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 3.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.0 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 5.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.0 | 8.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.0 | 3.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.0 | 2.9 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.0 | 1.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
1.0 | 2.9 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.0 | 4.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.0 | 1.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.0 | 1.9 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.0 | 1.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.9 | 1.9 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.9 | 2.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 1.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.9 | 3.7 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.9 | 2.7 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.9 | 0.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.9 | 1.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.9 | 4.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.9 | 3.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 1.8 | GO:0033058 | directional locomotion(GO:0033058) |
0.9 | 6.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.9 | 4.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.9 | 4.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.9 | 4.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 7.6 | GO:0060013 | righting reflex(GO:0060013) |
0.8 | 2.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.8 | 5.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.8 | 2.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.8 | 7.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.8 | 0.8 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.8 | 5.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.8 | 1.6 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.8 | 3.2 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.8 | 0.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.8 | 1.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.8 | 5.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 0.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.8 | 2.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 0.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.8 | 2.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 2.3 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.8 | 2.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.8 | 3.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 1.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.8 | 10.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.8 | 13.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.7 | 0.7 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.7 | 6.7 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.7 | 6.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.7 | 2.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.7 | 5.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 2.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.7 | 2.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 2.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.7 | 1.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.7 | 1.4 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.7 | 1.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 2.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 0.7 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.7 | 2.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 2.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.7 | 2.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 | 2.7 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 0.7 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.7 | 2.0 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 14.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 2.6 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 1.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.6 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 1.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.6 | 1.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.6 | 1.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 2.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.6 | 3.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 3.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 1.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.6 | 1.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.6 | 1.2 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 0.6 | GO:1903802 | amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.6 | 3.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 2.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 0.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 4.0 | GO:0001964 | startle response(GO:0001964) |
0.6 | 2.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.6 | 1.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.5 | 4.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 6.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 1.6 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.5 | 2.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 1.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 3.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.5 | 1.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.5 | 2.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 1.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 2.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 2.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.5 | 0.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.5 | 3.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 1.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 1.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 4.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.5 | 0.5 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.5 | 1.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.5 | 3.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.5 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 1.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 1.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 1.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.5 | 1.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.5 | 1.0 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 1.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 1.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 1.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 4.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 1.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 0.9 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.5 | 7.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.5 | 1.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 1.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 2.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.5 | 2.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 1.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 0.9 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.5 | 0.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.5 | 1.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.5 | 2.3 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.5 | 0.9 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 1.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 5.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 0.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 1.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.4 | 1.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.4 | 1.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 1.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 1.3 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.4 | 0.8 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 0.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.4 | 0.4 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.4 | 3.7 | GO:0048265 | response to pain(GO:0048265) |
0.4 | 0.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.4 | 3.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 1.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 6.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.4 | 0.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.4 | 1.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.4 | 1.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 6.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 1.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 1.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 0.8 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 3.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.4 | 3.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 5.0 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.4 | 0.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 1.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 1.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 1.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 4.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 1.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 1.9 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 0.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 1.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 1.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 1.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 2.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 0.7 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 17.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 1.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 1.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 0.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 1.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 0.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.4 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 2.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 2.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.3 | 1.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 5.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 0.7 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.3 | 1.4 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 1.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 1.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.0 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 1.0 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 4.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 0.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 2.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 2.6 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 1.0 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 1.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 1.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 1.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 4.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.3 | 0.9 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.3 | 0.9 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.3 | 22.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 1.2 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.3 | 1.5 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 1.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 0.6 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.3 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.9 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 1.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 1.5 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 1.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 0.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 0.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 0.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 5.5 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 0.9 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 1.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.3 | 1.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.9 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 1.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 1.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 0.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 1.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 1.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 2.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.3 | 0.8 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 1.9 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.3 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 1.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 0.8 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 1.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 1.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 2.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 1.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 0.8 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 0.3 | GO:0021756 | striatum development(GO:0021756) |
0.3 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 3.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 1.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 1.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 8.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 0.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.3 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 0.8 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.2 | 1.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.7 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.2 | 0.7 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.2 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 1.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.5 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.2 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.7 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.7 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 1.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 2.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 1.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 1.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.5 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 1.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.9 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 0.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 1.1 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 1.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 1.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.6 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 0.8 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.4 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 1.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 1.7 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 2.7 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.0 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.2 | 0.6 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.9 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 5.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 1.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.2 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.2 | 4.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 0.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.4 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.2 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 0.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 0.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.3 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 0.8 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.2 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.8 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.5 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.2 | 0.3 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 0.2 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 0.3 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.2 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.2 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.2 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.5 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 1.1 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 1.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.2 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.4 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 3.1 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.6 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 1.0 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.5 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.6 | GO:0086009 | membrane repolarization(GO:0086009) |
0.1 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 1.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.6 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 1.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 3.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 1.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.0 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 2.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 5.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.8 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.1 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.8 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 1.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.1 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 1.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 1.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.5 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.1 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.2 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.6 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 3.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.4 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 2.2 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 1.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.2 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.1 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.0 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.0 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.2 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.2 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.5 | GO:0098868 | bone growth(GO:0098868) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.6 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.0 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.3 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.2 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.0 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 11.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.6 | 16.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 7.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 4.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.2 | 14.3 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 3.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.0 | 3.0 | GO:0097441 | basilar dendrite(GO:0097441) |
1.0 | 2.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 7.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 3.7 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 2.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 7.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.8 | 2.5 | GO:0071942 | XPC complex(GO:0071942) |
0.8 | 5.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 2.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.7 | 3.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.7 | 4.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.7 | 2.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 18.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 2.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 1.9 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 9.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 6.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 1.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 1.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 34.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 4.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 6.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.6 | 2.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 9.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 1.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 3.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.5 | 2.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 1.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 3.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 1.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 5.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 3.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 2.2 | GO:0097433 | dense body(GO:0097433) |
0.4 | 3.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 20.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 2.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 9.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 12.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 3.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.4 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 1.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 0.7 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 1.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 2.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 1.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 2.2 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 0.9 | GO:0071438 | invadopodium(GO:0071437) invadopodium membrane(GO:0071438) |
0.3 | 43.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 1.5 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 2.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 0.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.4 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 3.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 3.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 1.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 0.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 26.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 2.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 3.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.9 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 2.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 1.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 2.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 2.6 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.7 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 3.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 2.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 7.4 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 11.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 3.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 6.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 3.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 3.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.0 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 3.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.5 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.9 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.8 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 7.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 1.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.2 | 9.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.5 | 12.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.9 | 9.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.8 | 12.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.6 | 7.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.5 | 7.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.5 | 3.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.4 | 4.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 4.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.3 | 1.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.3 | 3.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.3 | 5.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.2 | 3.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 3.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.2 | 3.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 4.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.1 | 3.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.1 | 4.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.1 | 3.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 3.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.0 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 4.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.0 | 3.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.0 | 2.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.9 | 6.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.9 | 3.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.9 | 2.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.9 | 2.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 0.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 4.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 2.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.8 | 4.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.8 | 1.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 2.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 2.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 3.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 2.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 4.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 4.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 3.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.6 | 5.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.6 | 3.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.6 | 19.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.6 | 1.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 18.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 5.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.6 | 1.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 2.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 1.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 5.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 1.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 1.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.6 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 5.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.6 | 2.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 9.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 1.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 2.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 2.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.5 | 2.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 1.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 10.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 2.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 2.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 2.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 4.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 2.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 0.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.5 | 4.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 2.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 1.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 1.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 4.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 1.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 0.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 2.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 1.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 1.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 0.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 0.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 2.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 3.7 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 1.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 1.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 2.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.4 | 1.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 3.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.4 | 1.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 1.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 7.1 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.4 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 1.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 5.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 2.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 3.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 6.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 2.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 4.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 2.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.3 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 2.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 1.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.3 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.6 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 2.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 0.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 3.7 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 2.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 2.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 2.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 4.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 6.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 1.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 1.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 1.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 7.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 2.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 0.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 2.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 3.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 3.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 6.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 2.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 7.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 2.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 3.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 2.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 2.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 2.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 1.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 3.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 3.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 1.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 1.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 2.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 1.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.1 | GO:0018642 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 1.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 5.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.7 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 2.8 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 3.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 2.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.6 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.6 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.0 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 2.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 2.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 10.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 2.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 1.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 3.9 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0018597 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.7 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 2.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 2.5 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 19.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 4.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 12.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 1.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 4.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 5.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 4.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 12.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 5.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 4.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 12.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 15.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.1 | 15.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 33.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 6.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 0.7 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.7 | 7.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 12.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 10.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 8.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.5 | 6.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 4.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 11.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 5.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 10.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 4.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 7.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 4.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.4 | 1.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 6.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 6.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 3.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 2.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 3.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 2.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 2.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 4.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 3.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 2.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 0.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 3.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 5.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 3.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 4.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |